gms | German Medical Science

21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin e. V.

Deutsches Netzwerk Evidenzbasierte Medizin e. V.

13. - 15.02.2020, Basel, Schweiz

How credible is a subgroup claim? Hands-on workshop using the new ICEMAN tool

Meeting Abstract

  • Stefan Schandelmaier - University of Basel, Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, Basel, Schweiz
  • Viktoria Gloy - University of Basel, Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, Basel, Schweiz
  • Andreas Schmitt - University Hospital Basel, Department of Oncology, Basel, Schweiz
  • Matthias Briel - University of Basel, Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, Basel, Schweiz

Nützliche patientenrelevante Forschung. 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin. Basel, Schweiz, 13.-15.02.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. Doc20ebmS2-WS1-01

doi: 10.3205/20ebm153, urn:nbn:de:0183-20ebm1535

Veröffentlicht: 12. Februar 2020

© 2020 Schandelmaier et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Description: Most randomized controlled trials and meta-analyses include analyses of effect modification (mostly in the form of subgroup analyses) to assess whether the effect of an intervention varies by another variable (e.g. age or disease severity). Assessing the credibility of an apparent effect modification presents challenges. Together with an international group of experts, we have developed a new Instrument for assessing the Credibility of Effect Modification ANalyses (ICEMAN).

The workshop is open for anyone interested in performing or interpreting trials or meta-analyses. After a brief overview, groups of participants will have the opportunity to test ICEMAN and assess published claims of effect modification that we provide. We will clarify conceptual and practical issues that arise during the exercises.

For any questions, or to see the material in advance, please write to s.schandelmaier@gmail.com

Intended methods: The target audience are researchers who are interested or involved in performing, interpreting, or assessing the quality of subgroup analyses in clinical trials or meta-analyses.

At the workshop, we will give an overview of effect modification/subgroup effects in randomized trials and meta-analyses, associated challenges, and present the new instrument. Groups of participants will then have the opportunity to apply ICEMAN to claims of effect modification that we provide. We will discuss the results and clarify conceptual and practical issues that arise during the exercises. Participants will learn about common pitfalls in subgroup analyses and how to use the instrument in practice. We will collect feedback on how we could improve the user-friendliness of future versions of ICEMAN.

Note: The paper is currently in revision; a related dissertation is [1].

Competing interests: Keine


References

1.
Schandelmaier S. Evaluating the credibility of effect modification claims in randomized controlled trials and meta-analyses [PhD thesis]. 2019. Available from: http://hdl.handle.net/11375/24375 Externer Link